Cargando…
Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors
BACKGROUND: Reprogramming of cancers into normal-like tissues is an innovative strategy for cancer treatment. Recent reports demonstrate that defined factors can reprogram cancer cells into pluripotent stem cells. Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor...
Autores principales: | Yuan, Jie, Zhang, Fan, Hallahan, Dennis, Zhang, Zhen, He, Liming, Wu, Ling-Gang, You, Meng, Yang, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090992/ https://www.ncbi.nlm.nih.gov/pubmed/30071868 http://dx.doi.org/10.1186/s13046-018-0857-5 |
Ejemplares similares
-
Retraction Note: Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors
por: Yuan, Jie, et al.
Publicado: (2021) -
RETRACTED ARTICLE: Identification of protein kinase inhibitors to reprogram breast cancer cells
por: Yuan, Jie, et al.
Publicado: (2018) -
Retraction Note: Identification of protein kinase inhibitors to reprogram breast cancer cells
por: Yuan, Jie, et al.
Publicado: (2022) -
Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery
por: Brar, Harpinder K., et al.
Publicado: (2022) -
A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiforme
por: Nehoff, Hayley, et al.
Publicado: (2015)